OOIR: Observatory of International Research

Papers

(The median citation count of JAMA Cardiology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Anticipating Pharmacological Perturbation With Human Genetic Variation—Lessons From CETP	292
A Woman With Recurrent Torsade de Pointes	255
A Patient in His 50s With Chest Tightness and Left Arm and Neck Tingling	252
The Case for Inclusion of a Lipid Panel in the Standard Precatheterization Laboratory Blood Draw—Stating What Should Be Obvious	202
Identifying Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction—Reply	198
Error in Table 1	197
Educational Attainment and Cardiovascular Risk—A Missed Opportunity?	175
JAMA Cardiology	171
Mendelian Randomization and Cardiovascular Disease—Enabling Expert Readership	170
Ventricular Septal Rupture After ST-Segment Elevation Myocardial Infarction	169
Implementing Shared Decision-making for Patients With Aortic Stenosis With Longer Life Expectancy	142
Chest Pain in a Middle-Aged Man	137
Smoking Cessation Improves Outcomes in Patients With Peripheral Artery Disease	120
JAMA Cardiology	119
USPSTF Report on Aspirin for Primary Prevention	111
Accountable Care Organization Participation and Cardiovascular Care Quality	107
Mining the Electronic Medical Record for Hypertension Treatment—Hope or Hype?	106
Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event—Moving Beyond C Statistic	105
Finding Pulmonary Arterial Hypertension—Switching to Offense to Mitigate Disease Burden	102
Genome-Wide Association Study of Accessory Atrioventricular Pathways	100
Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement	97
Long-Term Changes in Ventricular Function in Recreational Marathon Runners	96
Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial Infarction	95
Association of Longer Leukocyte Telomere Length With Cardiac Size, Function, and Heart Failure	94
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF	93

Blood Pressure Measurements From Self-Service Health Kiosks in US Retail Stores, 2017-2024	93
Primary Prevention Management of Elevated Lipoprotein(a)	92
Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors	91
Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes	88
Spontaneous Coronary Artery Dissection in a Healthy Man With Non–ST Elevation Myocardial Infarction	87
JAMA Cardiology	87
Supraventricular Tachycardia Following Mitral Valve Surgery	86
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	86
JAMA Cardiology	83
What Is Your Secret to Health?	82
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target—Reply	81
Hypertriglyceridemia in the MESA Study—Reply	80
Interpreting Health Status Measures in Patients With Heart Failure—What Counts	79
Innovation in Event Adjudication—Human vs Machine	79
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease	74
Peak Oxygen Uptake vs Ventilatory Efficiency	74
Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction	73
Race, Racism, and Risk—Implications of Social Determinants of Health in Cardiovascular Disease Prediction	72
Effect of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm	72
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?	71
User Trust in Artificial Intelligence–Guided Lung Ultrasound	69
Critical Appraisal of the Negative Predictive Performance of the European Society of Cardiology 0/1-Hour Algorithm for Evaluating Patients With Chest Pain in the US	66
Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features	65
Contribution of Clinical Trial Event Data by Data Source	65
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone	65
Circulating Trimethylamine N-Oxide and Growth Rate of Abdominal Aortic Aneurysms and Surgical Risk	64
A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy–Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer	64
Left Atrial Appendage Closure After Thrombus Aspiration—Reply	63
Artificial Intelligence–Guided Lung Ultrasound by Nonexperts	62
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	60
Error in Figure	60
Corrected to Open Access Status	60
Achieving Equitable Access to Acute Myocardial Infarction Therapies for Rural Patients—Is It Possible?	60
Optimizing Cascade Testing to Advance Health Equity in Cardiac Amyloidosis	58
Young Man With Coarctation of the Aorta	58
PCSK9 in Familial Hypercholesterolemia and Beyond	58
JAMA Cardiology	58
Geographical and Urban-Rural Disparities in Cardiac Rehabilitation Eligibility and Center-Based Use in the US	57
JAMA Cardiology	57
Clinical Decisions and Outcomes After Switching High-Sensitivity Cardiac Troponin Assays in Suspected ACS	56
Epicardial and Pericardial Fat—Separated But Under the Same Roof—Reply	56
Potassium Nitrate in Heart Failure With Preserved Ejection Fraction	55
Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes	54
Circumferential Pulmonary Vein Isolation With vs Without Additional Low-Voltage-Area Ablation in Older Patients With Paroxysmal Atrial Fibrillation	54
Error in Nonauthor Collaborator’s Name	54
Supine Blood Pressure and Risk of Cardiovascular Disease and Mortality	53
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1	52
Professional Preferences and Perceptions of Cardiology Among Internal Medicine Residents	52
Association of Complement and MAPK Activation With SARS-CoV-2–Associated Myocardial Inflammation	51
Atherosclerotic Coronary Plaque Regression and Risk of Adverse Cardiovascular Events	51

Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk	50
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	50
Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection	50
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	49
Exertional Dyspnea in a Female Patient Aged 55 Years Without Significant Medical History	49
To Occlude or Not to Occlude the Left Atrial Appendage in Women	49
JAMA Cardiology	49
A Woman With Syncope and Frequent Premature Ventricular Contractions	49
The Urgent Need to Improve Outcomes for Pregnant Cardiovascular Trainees	48
Passing the Stethoscope	48
Importance of Prolonged QRS Duration in Detecting Complete Conduction Block	47
Error in Abstract and Results	47
The Politics of HFpEF—What’s Good for the Left Is Good for the Right	47
Error in Figure 1	46
Troponins and Pregnancy—Reply	46
Current Landscape and Future Directions of Coronary Revascularization in Patients With Heart Failure	45
Exercise and Resistant Hypertension—Is Exercise Enough?—Reply	45
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy	44
Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure—A Call to Action	44
The 3.5-Inch View—On Perspective and the Medical Profession	44
High-Sensitivity Troponin T and I Among Pregnant Women in the US—The National Health and Nutrition Examination Survey, 1999-2004	43
Athletes With Cardiovascular Disease and Competitive Sports Eligibility	42
Clonal Hematopoiesis—Fuel to Inflame the Heart	42
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease	42
When Is a Placebo Not a Placebo	42
Concomitant Mechanical Aspiration and Appendage Closure for Recalcitrant Left Atrial Appendage Thrombi	41
Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US	41
State-Level Cardiovascular Mortality Rates Among Hispanic, Non-Hispanic Black, and Non-Hispanic White Populations, 1990 to 2019	41
Aggressive Risk Factor Reduction Study for Atrial Fibrillation Implications for Ablation Outcomes	41
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy	41
Prioritizing the Exposome to Reduce Cardiovascular Disease Burden	40
Preserving and Promoting Clinical Trial Representativeness	40
Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines	40
Early Mortality in Type A Acute Aortic Dissection	40
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials	40
In Honor of the Pig	39
Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction	39
Cardiovascular Significance and Genetics of Epicardial and Pericardial Adiposity	39
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the US	39
JAMA Cardiology	38
Incidental Complication From a Left Atrial Appendage Device	38
Is CABG Indicated in Patients With Ischemic Cardiomyopathy?	37
My Grandfather’s Blueprint	37
A 65-Year-Old Woman With Dyspnea and Recurrent Abdominal Distension	37
An Elderly Woman With Ventricular Tachycardia	37
The Smart(est) Choice for Dual Antiplatelet Therapy Is a Patient-Directed One	37
JAMA Cardiology	37
Reflections of an Editorial Fellow—A Window Into Medical Publishing	36
Errors in Author Affiliations and Open Access Updated	36
Error in Abstract	36
JAMA Cardiology	36
Error in Table	36
Corrected to Open Access Status	36
The Limitations and Risks Associated With Semaglutide Treatment—Reply	35
Preventing Declines in Cardiovascular Health From Childhood	35
Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure	35
Improving Behavioral Counseling for Primary Cardiovascular Disease Prevention	35
PREVENT Risk Age Equations and Population Distribution in US Adults	34
Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality	34
Error in Results	34
Finerenone in Heart Failure—Reply	34
Predicting the Risk of Myocardial Infarction vs the Risk of Stroke in Hypertension—Reply	34
The Last Mile in Prevention—Can Coronary CT Angiography Help?	34
One-Year Outcomes of Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST Elevation	33
Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart Failure	33
Tenecteplase vs Alteplase in Mechanical Prosthetic Heart Valve Thrombosis	33
Effectiveness of a Text-Based Gamification Intervention to Improve Physical Activity Among Postpartum Individuals With Hypertensive Disorders of Pregnancy	33
Indication Creep in Transcatheter Aortic Valve Implantation—Data or Desire?	33
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV	32
Cardiovascular Health Among Rural and Urban US Adults—Healthcare, Lifestyle, and Social Factors	32
Age-Adjusted Survival Extrapolations—Results May Differ From Those Generated by the Weibull Model—Reply	31
JAMA Cardiology	31
Bizarre Wide-Complex Tachycardia in a Man in His 60s With Severe Chest Pain	31
Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations	31
Moving Beyond Conventional Guesstimation to Guide PCI	30
A Man in His 60s With Severe Heart Failure and Incessant Ventricular Arrhythmias	30
A Young Woman With Dyspnea During Cardiac Catheterization	30
Medical Editors vs Nuclear Weapons—Is the Pen Mightier Than the Sword?	30
Medicine, Writing, and the Limits of Language	30
Trends in Transcatheter vs Surgical Mitral Valve Repair Among Medicare Beneficiaries, 2012 to 2019	29

Updated USPSTF Guidelines for Screening for Atrial Fibrillation	29
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk	29
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial	29
JAMA Cardiology	29
Fontan Junctional Rhythm—Innocent Bystander or Silent Killer?	29
Comment on Aspirin Avoidance in Patients With LVADs	29
High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients With Acute Pulmonary Embolism	28
Prevalence and Trends of Coronary Heart Disease in the United States, 2011 to 2018	28
Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	28
Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure	28
Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	28
Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement	28
Antibiotic Prophylaxis and Infective Endocarditis Incidence Following Invasive Dental Procedures	27
Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock	27
What Role for New York Heart Association Class in Heart Failure Clinical Trials?	27
Man in His Sixth Decade of Life With Totally Occluded Abdominal Aorta (Leriche Syndrome)	26
How Do We Credit the Evidence Generated From Subgroup Analyses in Randomized Clinical Trials?—Reply	26
A Man in His 60s With Pneumonia and Multiple Reintubation Attempts	26
To Occlude or Not to Occlude the Left Atrial Appendage in Women—Reply	26
More Attention Should Be Paid to Less Severe Nonculprit Lesions—Reply	26
JAMA Cardiology	26
JAMA Cardiology	26
A Teenager With Palpitations	26
A Man in His 20s With Gradually Enlarging Mediastinal Mass and Intermittent Hemoptysis	26
Role of Income-Lifting Social Programs in Reducing Years of Life Lost to Myocardial Infarction and Sudden Death	25
Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults	25
Is There a Need for Palliative Care for Patients With Heart Failure With Preserved Ejection Fraction?	25
The Fine Art and Science of Translating Trials Results Into Clinical Practice	25
Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease	25
Myocardial Dysfunction in Primary Mitral Regurgitation	24
Plasma Proteomics of Exercise Blood Pressure and Incident Hypertension	24
Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy–Related Cardiomyopathies	24
Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation	24
Trends in 10-Year Outcomes Among Medicare Beneficiaries Who Survived an Acute Myocardial Infarction	24
Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both	24
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	23
Transient Monocular Blindness in a Man in His 30s	23
Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension	23
A Simplified Method for the Diagnosis of Constrictive Pericarditis in the Cardiac Catheterization Laboratory	23
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?—Reply	23
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target	23
Emergency Medical Service Agency Practices and Cardiac Arrest Survival	23
Patient Enrollment for Cardiovascular Clinical Trials in the United States	23
Authenticity—An Uphill Battle for a Black Woman in Cardiology	23
Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management	23
Genetic Testing in Early-Onset Atrial Fibrillation	22
Salt Substitution and Recurrent Stroke and Death—Reply	22
Error in Abstract and Methods	22
Hard Lessons From a School-Based Intervention to Improve Cardiovascular Health in Adolescence	22
Chest Tube–Induced Right Ventricular Failure After Cardiac Surgery	22
JAMA Cardiology	22
Heart Failure and Nonoptimal Temperatures	21
AI-Assisted Point-of-Care Ultrasound Networks—Considerations for Rural Health Care Delivery	21
Inquiry Regarding Body Temperature Data in HuMAIN-HFpEF Trial	21
Hospitalization Rates Alone Do Not Define Health Systems—Reply	21
Women’s Representation in Interventional Cardiology	21
Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US	21
Time to Revisit Using 10-Year Risk to Guide Statin Therapy	20
High-Risk Areas—The Trees in the Forest—Reply	20
Private Equity and Cardiovascular Health Care	20
Periconceptional Glucagon-Like Peptide-1 Receptor Agonist Use and Discontinuation	20
Carotid Artery Stenosis—An Impactful Bias in Ischemic Stroke Classification	20
Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery Disease	20
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients	20
Adverse Pregnancy Outcomes and N-Terminal Pro-Brain Natriuretic Peptide Levels 2 to 7 Years After Delivery	20
Variants at the Interleukin 1 Gene Locus and Pericarditis	19
Emergency Department–Based Education and mHealth Empowerment Intervention for Hypertension	19
Discontinuation of Semaglutide Among Older Adults With Diabetes in the US and Japan	19
Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation	19
Long-term Survival After Out-of-Hospital Cardiac Arrest	19
Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic Stenosis	19
Blood Pressure Control After SPRINT—Back to Reality	19
Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis	18
Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction	18
Reducing the Risks of Nuclear War—The Role of Health Professionals	18
JAMA Cardiology Peer Reviewers in 2021	18
Comprehensive Cardiovascular Magnetic Resonance Tissue Characterization and Cardiotoxicity in Women With Breast Cancer	18
Heart Failure—Together We Go Farther—Reply	18
Recommendations for Deferred Testing in Low-Risk Chest Pain—Decades Old But Now Finally Tested	18
Omitted Affiliation	18
Educational Attainment and Lifetime Risk of Cardiovascular Disease	18
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020	18
Error in the First Paragraph	18
Errors in Abstract	17
Can Noncalcified Plaques Contribute to Future Coronary Events?	17
What’s VAT All About—The Clue Is in the Genetics	17
Exercise-Induced Dyspnea in an Older Woman With a History of Coronary Artery Disease	17
Management of Postpartum Left Main Spontaneous Coronary Artery Dissection	17
Error in Figure 1	17
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV	16
Electrocardiographic Findings in Female Professional Basketball Athletes	16
Hypertensive Disorders of Pregnancy and Long-Term Risk of Dilated Cardiomyopathy	16
Social Vulnerability and Poor Health Outcomes	16
Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	16
Treating Severe Hypercholesterolemia—If Not Now, When?	16